Not applicableStudy completedNCT02111889What this trial is testingTumor Kinase Inhibitor Concentrations Measured by PETWho this might be right forDisseminated Malignant Neoplasm Amsterdam UMC, location VUmc 8
Early research (Phase 1)Study completedNCT02070549What this trial is testingTrametinib in Treating Patients With Advanced Cancer With or Without Hepatic DysfunctionWho this might be right forAdvanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Solid Neoplasm+1 more National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585320What this trial is testingA Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorPancreatic AdenocarcinomaMalignant Melanoma (Cutaneous)+1 more Immuneering Corporation 209
Early research (Phase 1)Active Not RecruitingNCT05311397What this trial is testingA166 in Patients With Advanced Solid Malignant TumorsWho this might be right forBreast Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 120
Early research (Phase 1)Looking for participantsNCT07260305What this trial is testingA Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor PatientsWho this might be right forAdvanced or Metastatic Solid Tumors Kangabio AUSTRALIA LTD PTY 57
Testing effectiveness (Phase 2)WithdrawnNCT07511972What this trial is testingStudy of NGM707 in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesWho this might be right forCRC NGM Biopharmaceuticals, Inc
Early research (Phase 1)UnknownNCT05554666What this trial is testingASKG315 in Patients With Advanced Solid Tumors.Who this might be right forAdvanced Solid Tumors AskGene Pharma, Inc. 56
Early research (Phase 1)Study completedNCT01822522What this trial is testingCabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency VirusWho this might be right forAdvanced Malignant Solid NeoplasmHIV InfectionMetastatic Malignant Solid Neoplasm+2 more National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT01976741What this trial is testingDose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)Who this might be right forNeoplasms Bayer 168
Early research (Phase 1)Study completedNCT00761696What this trial is testingIPI-926 in Patients With Advanced and/or Metastatic Solid Tumor MalignanciesWho this might be right forNeoplasms Infinity Pharmaceuticals, Inc. 94
Early research (Phase 1)Active Not RecruitingNCT06545942What this trial is testingStudy of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorMetastatic Solid TumorProstate Cancer+4 more MOMA Therapeutics 220
Early research (Phase 1)Active Not RecruitingNCT05678010What this trial is testingAZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor CancerWho this might be right forSolid TumorMetastatic Solid TumorSolid Carcinoma+3 more Memorial Sloan Kettering Cancer Center 54
Testing effectiveness (Phase 2)Looking for participantsNCT03907475What this trial is testingDurvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ TrialWho this might be right forLocally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm National Cancer Institute (NCI) 115
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07307053What this trial is testingRare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)Who this might be right forRare Malignant NeoplasmAdvanced Solid TumorsMetastatic Solid Tumors Cancer Institute and Hospital, Chinese Academy of Medical Sciences 600
Early research (Phase 1)Looking for participantsNCT06548672What this trial is testingAssess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or Metastatic CancerWho this might be right forAdvanced CancerMetastatic Solid Tumor Biocity Biopharmaceutics Co., Ltd. 148
Early research (Phase 1)Study completedNCT00878904What this trial is testingPanobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid TumorsWho this might be right forUnspecified Adult Solid Tumor, Protocol Specific University of California, San Francisco 40
Early research (Phase 1)Ended earlyNCT05047536What this trial is testingKZR-261 in Subjects With Advanced Solid MalignanciesWho this might be right forAdvanced/Metastatic Solid Tumor Kezar Life Sciences, Inc. 61
Testing effectiveness (Phase 2)Ended earlyNCT06682806What this trial is testingPRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 MutationWho this might be right forAdvanced Solid TumorEsophageal CancerMetastatic Solid Tumor+2 more Prelude Therapeutics 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07327294What this trial is testingA Phase I/II Study to Evaluate XNW34017 in Patients With Advanced or Metastatic Solid TumorWho this might be right forAdvanced Solid Tumors Evopoint Biosciences Inc. 150
Early research (Phase 1)Ended earlyNCT05233436What this trial is testingPF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorsGastric CancerGastroesophageal Junction Cancer+3 more Pfizer 21